Market Overview

Benzinga's Top #PreMarket Losers

Benzinga's Top Downgrades
UBS Downgrades Catamaran To Neutral
5 Biotech Stocks On Deck With The FDA
Sell The News In Sarepta Therapeutics
Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal, BioMarin/Sarepta DMD Drugs Progress - Analyst Blog (Zacks)

Catamaran (NASDAQ: CTRX) shares fell 9.27% to $47.00 in the pre-market trading after the company reported Q4 results.

Sarepta Therapeutics (NASDAQ: SRPT) dipped 4.89% to $28.01 after the company reported weaker-than-expected results.

Magic Software Enterprises (NASDAQ: MGIC) shares dropped 2.19% to $9.39 in pre-market trading after rising 6.31% on Wednesday.

InterMune (NASDAQ: ITMN) dipped 2.08% to $31.51 in the pre-market session after dropping 14.87% on Wednesday.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (ITMN + CTRX)

Around the Web, We're Loving...

Get Benzinga's Newsletters